SCHEMBL28265778

SCHEMBL28265778

NCCCNc1cc(Cl)nc(N)n1

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.68
CYP2C19 P33261 1/20 0.68
HRH4 Q9H3N8 7/20 0.60
SMN1; SMN2 Q16637 2/20 0.56
ALDH1A1 P00352 2/20 0.56
HRH3 Q9Y5N1 1/20 0.54
TLR8 Q9NR97 2/20 0.53
KMT2A Q03164 2/20 0.44
POLA1 P09884 1/20 0.44
MAPT P10636 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
STK17A Q9UEE5 1/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8600881 0.85 TLR8 (0.69) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
SCHEMBL8055803 0.85 CYP2D6 (0.81) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
SCHEMBL17315544 0.84 CYP2D6 (0.70) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
SCHEMBL11752857 0.83 CYP2D6 (0.64) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
SCHEMBL8048808 0.83 CYP2D6 (0.79) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL8053388 0.83 CYP2D6 (0.79) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL8049447 0.82 CYP2D6 (0.77) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
SCHEMBL7117794 0.82 CYP2D6 (0.62) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
SCHEMBL7124897 0.82 CYP2D6 (0.62) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1
SCHEMBL7118699 0.82 CYP2D6 (0.62) CYP2D6CYP2C19HRH4SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 CN disclosed